CentraState Healthcare System Implements SpectraMedix’s FOCUS Actionable Analytics Platform to Reduce Preventable Readmissions

The clinical and business intelligence solution will also help improve Value-Based Purchasing and Core Measure scores at the New Jersey Hospital

Princeton, NJ — January 8, 2012 — SpectraMedix, a provider of clinical and business intelligence solutions, announced today that it has implemented its FOCUS Actionable Analytics business intelligence platform at CentraState Healthcare System in Freehold, NJ. CentraState will use the FOCUS platform to support their enterprise data analytics and reporting initiatives, which include reducing preventable readmissions, improving Value-Based Purchasing and HCAHPS scores, and streamlining compliance with Core Measures.

“As we transition into performance-based and Accountable Care models of healthcare delivery,” said Indranil Ganguly, Vice President and Chief Information Officer at CentraState, “the FOCUS platform will help us fully leverage our data assets to improve quality, safety and efficiency.”

“Reducing preventable readmissions and improving HCAHPS and Value-Based Purchasing scores is a top priority for CentraState Healthcare System,” said Dr. Jack Dworkin, Vice President, Medical Affairs, and Chief Medical Officer at CentraState. “We are looking forward to using SpectraMedix’s solution to achieve these goals.”

FOCUS Actionable Analytics provides a robust and comprehensive method to analyze performance metrics that empowers hospitals, physicians and ambulatory care facilities to improve clinical quality and transition to performance and accountability based payment models. A cloud-based solution, FOCUS presents real-time, actionable data analytics and over 250 pre-built hospital and ambulatory key performance indicators (KPIs) across five fundamental areas of accountability: Financial, Operational, Clinical, Utilization and Satisfaction (FOCUS). With access to relevant and reliable information, decision-makers can measure and manage all aspects of care and succeed in initiatives such as preventable readmissions reduction, Value-Based Purchasing, HCAHPS and Accountable Care Organization participation.

FOCUS will enable CentraState stakeholders to:

  • Generate real-time and predictive analytics to identify patients at risk for readmissions
  • Support Case Managers with “Work Lists” to ensure appropriate care coordination prior to discharge and for post discharge follow-up
  • Alert the Emergency Department when a 30-day readmit presents to the hospital
  • Forecast the financial impact of readmission penalties
  • Assist with improving Value-Based Purchasing and HCAHPS scores in “near real-time”
  • Leverage role-based dashboards for the CFO, CMO, COO and other leadership at all organizational levels

“We are pleased to have the opportunity to work with CentraState Healthcare System again,” said Raj Lakhanpal, MD, CEO of SpectraMedix. “We look forward to assisting CentraState to receive full Medicare payments for the Readmissions Reduction and Value-Based Purchasing Programs by unlocking the value of their clinical data.”

About SpectraMedix

SpectraMedix empowers hospitals and ambulatory care providers to accelerate their quality improvement efforts and achieve their financial goals. Our business intelligence solutions offer real-time, actionable analytics across five key domains: Financial, Operational, Clinical, Utilization and Satisfaction (FOCUS). With access to relevant and reliable information, decision makers can measure and manage all aspects of care and succeed in initiatives such as readmissions reduction, Value-Based Purchasing and Accountable Care Organizations participation.

About CentraState Healthcare System

CentraState Healthcare System is a not-for-profit health organization providing a range of services through an acute-care medical center with 284 beds, an ambulatory campus housing a range of outpatient health and wellness services, three senior living communities, a family medicine residency program, and a charitable foundation. It is a member of the Robert Wood Johnson Health Network and a clinical research affiliate of The Cancer Institute of New Jersey, a National Cancer Institute-designated Comprehensive Cancer Center. Established in 1971, CentraState’s mission is to enhance the health and well-being of its community through the compassionate delivery of quality healthcare.

Share:
FacebookTwitterLinkedIn
Request a Demo
WP-Backgrounds Lite by InoPlugs Web Design and Juwelier Schönmann 1010 Wien